As of 05 Nov 2026 07:12 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2021/045 (13 Sep 2021): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Advanz Pharmaaffected product · inferred from phrasing | Discontinued, as stated | — not stated for this line | notice of 13 Sep 2021 |
| Metformin 850mg/5ml and 1000mg/5ml oral solutionsnamed by the source as remaining available · inferred from phrasing | Stated as available; cannot support an uplift in demand | — not stated for this line | notice of 13 Sep 2021 |
| Metformin 500mg powder for oral solution sugar freenamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 13 Sep 2021 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Metformin 850mg/5ml and 1000mg/5ml oral solutions — named by the source as remaining available (inferred from phrasing)
- Metformin 500mg powder for oral solution sugar free — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Metformin
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 13 Sep 2021. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 13 Sep 2021 | Medicine Supply Notification: Metformin 500mg/5ml oral solution | Supply notification | Tier 2 | MSN/2021/045 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2021)20 Pioglitazone 15mg/metformin 850mg (Competact®) tablets · issued 22 Apr 2021 · valid until early May 2021, as stated · matched by name PDF ↗